Clinical trials: Type 1 Diabetic Nephropathy

Diabetic Kidney Disease

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

• Completed
• Age: 18 years and older
• Phase 2

The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the treatment of adult participants with a diagnosis of Diabetic Kidney Disease due…

Trial name

NCT05514548

Testing

INV-202

Where

72 sites in United States, Canada and 5 more

Volunteers

265 people

Sponsor

Inversago Pharma Inc.